News
WALD
1.050
+0.96%
0.010
Weekly Report: what happened at WALD last week (0406-0410)?
Weekly Report · 23h ago
Weekly Report: what happened at WALD last week (0330-0403)?
Weekly Report · 04/06 09:16
Weekly Report: what happened at WALD last week (0323-0327)?
Weekly Report · 03/30 09:16
Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness
Barchart · 03/24 07:35
Weekly Report: what happened at WALD last week (0316-0320)?
Weekly Report · 03/23 09:16
Waldencast's Obagi Medical Announces Collaboration With ProMD Health As Part Of Obagi's Hyaluronic Acid Program
Benzinga · 03/19 13:42
Obagi Medical, ProMD collaborate for ALOHA program
TipRanks · 03/19 12:30
Obagi Medical partners with ProMD Health in ALOHA Program to evaluate saypha MagIQ
Reuters · 03/19 12:29
Waldencast plc files initial beneficial ownership statement for CEO Michel Brousset
Reuters · 03/18 16:13
Waldencast plc files Form 3 initial beneficial ownership statement for director and 10% owner Cristiano Souza
Reuters · 03/18 15:26
Waldencast plc director Roberto Thompson Motta files initial beneficial ownership statement
Reuters · 03/18 15:24
Waldencast plc director Aaron Chatterley files initial beneficial ownership statement
Reuters · 03/18 14:34
Waldencast plc CFO Manuel Manfredi files initial beneficial ownership statement
Reuters · 03/18 14:32
Waldencast plc files Form 3 initial beneficial ownership statement for Chief Growth Officer Hind Sebti
Reuters · 03/18 14:28
Waldencast plc Director Brookie Kelly files initial beneficial ownership statement
Reuters · 03/18 14:26
Waldencast price target lowered to $2.50 from $3.50 at Alliance Global
TipRanks · 03/17 11:16
Waldencast Price Target Cut to $2.00/Share From $3.00 by Telsey Advisory Group
Dow Jones · 03/16 19:13
Waldencast Is Maintained at Market Perform by Telsey Advisory Group
Dow Jones · 03/16 19:13
Telsey Advisory Group Maintains Market Perform on Waldencast, Lowers Price Target to $2
Benzinga · 03/16 19:03
Waldencast Price Target Cut to $2.00/Share From $4.00 by Canaccord Genuity
Dow Jones · 03/16 16:27
More
Webull provides a variety of real-time WALD stock news. You can receive the latest news about Waldencast plc through multiple platforms. This information may help you make smarter investment decisions.
About WALD
Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.